Supplementary Figure 8 from T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
Authors:
- Justin F. GainorJGJustin F. Gainor
- Manish R. PatelMPManish R. Patel
- Jeffrey S. WeberJWJeffrey S. Weber
- Martin GutierrezMGMartin Gutierrez
- Julie E. BaumanJBJulie E. Bauman
- Jeffrey M. ClarkeJCJeffrey M. Clarke
- Ricklie JulianRJRicklie Julian
- Aaron J. ScottASAaron J. Scott
- Jessica L. GeigerJGJessica L. Geiger
- Kedar KirtaneKKKedar Kirtane
- Celine Robert-TissotCRCeline Robert-Tissot
- Brandon CoderBCBrandon Coder
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)